Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01685229 · ClinicalTrials.gov registry record

Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis

A clinical trial of Sinusitis, sponsored by Integra LifeSciences Corporation.

Completed
Registry status
198
Enrollment target
20
Study locations

NCT01685229 is a study of Sinusitis that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 198 participants, above the 114-participant average among 12 other Sinusitis trials with a reported enrollment target (74% higher). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01685229, a study of Sinusitis, has completed, sponsored by Integra LifeSciences Corporation.

COMPLETED
Registry status
198 participants
Enrollment target
20
Study locations

Study Summary

This post-market study aims to compare health outcomes for Chronic Rhinosinusitis (CRS) patients treated with balloon sinus dilation (BSD) versus continued medical management.

Conditions Studied

Interventions

  • DEVICE Balloon sinus dilation
  • DRUG Medical Management

Study Locations (20)

Georgia

  • - Atlanta
  • - Savannah
  • - Vidalia

Texas

  • - Frisco
  • - McKinney
  • - Plano

Virginia

  • - Charlottesville
  • - Norfolk
  • - Richmond

Florida

  • - Miami
  • - Tampa

Illinois

  • - Chicago
  • - Rockford

Wisconsin

  • - Beaver Dam
  • - Wauwatosa

Colorado

  • - Denver

Indiana

  • - South Bend

Trial Details

FieldValue
Enrollment Target 198 participants
Start Date 2012-09-01
Est. Completion 2015-08-01

Sponsor

Integra LifeSciences Corporation

60 total trials

What the Registry Record Tells You About NCT01685229

The ClinicalTrials.gov registry entry for NCT01685229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 114-participant average among 12 other Sinusitis trials with a reported enrollment target (74% higher). The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which Balloon sinus dilation is the first listed.

NCT01685229 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Georgia, Texas, Virginia.

Frequently Asked Questions

What is clinical trial NCT01685229 about?

NCT01685229 is a clinical study titled "Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis". This post-market study aims to compare health outcomes for Chronic Rhinosinusitis (CRS) patients treated with balloon sinus dilation (BSD) versus continued medical management.

What is the current status of trial NCT01685229?

This trial is currently completed. The enrollment target is 198 participants. The study started on 2012-09-01. Estimated completion is 2015-08-01.

What conditions does trial NCT01685229 study?

This clinical trial studies the following conditions: Sinusitis.

What interventions are being tested in trial NCT01685229?

The interventions under investigation include: Balloon sinus dilation (DEVICE), Medical Management (DRUG).

Who is sponsoring clinical trial NCT01685229?

This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01685229 being conducted?

This trial has 20 study locations across Colorado, Florida, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sinusitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.